|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
1 Molecular Medicine and Gene Therapy and Lund Strategic Center for Stem Cell Biology and Cell Therapy Lund University Hospital, 221 84 Lund, Sweden
2 Center for Regenerative Medicine and Technology, AIDS Research Center and Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: Ann.Brun{at}med.lu.se.
| Abstract |
|---|
Enforced expression of the HOXB4 transcription factor and downregulation of p21Cip1/Waf (p21) can each independently increase proliferation of murine hematopoietic stem cells (HSCs). We asked whether the increase in HSC self-renewal generated by overexpression of HOXB4 is enhanced in p21 deficient HSC. HOXB4 was overexpressed in hematopoietic cells from wild type (wt) and p21-/- mice. Bone marrow (BM) cells were transduced with a retroviral vector expressing HOXB4 together with GFP (MIGB4), or a control vector containing GFP alone (MIG) and maintained in liquid culture for up to 11 days. At day 11 of the expansion culture, the number of primary CFU-GM colonies and the repopulating ability were significantly increased in MIGB4 p21-/- BM (p21B4) cells compared to MIGB4 transduced wt BM (wtB4) cells. In order to test proliferation of HSC in vivo we performed competitive repopulation experiments and obtained significantly higher long-term engraftment of expanded p21B4 cells compared to wtB4 cells. The 5-day expansion of p21B4 HSCs generated 100-fold higher numbers of CRU compared to wtMIG, and 3-fold higher numbers compared to wtB4. The findings demonstrate that increased expression of HOXB4, in combination with suppression of p21 expression, could be a useful strategy for effective and robust expansion of HSCs.
Key Words. Hematopoiesis, HOXB4, p21, stem cell expansion
This article has been cited by other articles:
![]() |
J. L. Moody, S. Singbrant, G. Karlsson, U. Blank, M. Aspling, J. Flygare, D. Bryder, and S. Karlsson Endoglin Is Not Critical for Hematopoietic Stem Cell Engraftment and Reconstitution but Regulates Adult Erythroid Development Stem Cells, November 1, 2007; 25(11): 2809 - 2819. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Araki, K. Yoshinaga, P. Boccuni, Y. Zhao, R. Hoffman, and N. Mahmud Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential Blood, April 15, 2007; 109(8): 3570 - 3578. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van Os, L. M. Kamminga, A. Ausema, L. V. Bystrykh, D. P. Draijer, K. van Pelt, B. Dontje, and G. de Haan A Limited Role for p21Cip1/Waf1 in Maintaining Normal Hematopoietic Stem Cell Functioning Stem Cells, April 1, 2007; 25(4): 836 - 843. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
